The Filings Report

Sempra

SRENYSECIK 1032208Utilities / Utilities - Diversifiedfiscal year ends December66 quarters since 2009

Revenue, Q1 FY2026
—
no year-earlier figure
Net income
$1.0B
+14.5% on Q1 FY2025
Free cash flow
−$652M
+23.7% on Q1 FY2025
Diluted EPS
$1.58
+13.7% on Q1 FY2025
Revenue, TTM
—
trailing four quarters
Net margin, TTM
—
net income $1.9B
Free cash flow, TTM
−$5.8B
$4.9B less $10.7B capex
Cash and equivalents
$794M
long-term debt —, Mar 31, 2026
Shares, 12-month change
+0.2%
654M shares, Mar 31, 2026
Buybacks, TTM
$21M
0.0% of market value
Dividends, TTM
$1.6B
2.9% of market value
Market value
$56.3B
at the close, buybacks

Latest quarter Q1 FY2026, filed May 7, 2026. Trailing figures sum the latest four quarters. Market values at the latest close, from a market data vendor.

In Q1 FY2026, the quarter ended March 31, 2026, Sempra reported no revenue line, and net income of $1.0B (+14.5%). Free cash flow, operating cash flow less capital expenditures, was −$652M ($1.8B less $2.5B). Diluted earnings per share were $1.58.

The last 16 quarters

Q2 FY2022 to Q1 FY2026, through the filing of May 7, 2026.

Revenue and net incomeRevenueNet income
$0$2B$4B$6B$8BQ2'22, Revenue: $3.5BQ2'22, Net income: $559MQ2'22Q3'22, Revenue: $3.6BQ3'22, Net income: $485MQ3'22Q4'22, Revenue: $3.5BQ4'22, Net income: $438MQ4'22Q1'23, Revenue: $6.6BQ1'23, Net income: $969MQ1'23Q2'23, Revenue: $3.3BQ2'23, Net income: $603MQ2'23Q3'23, Revenue: $3.3BQ3'23, Net income: $721MQ3'23Q4'23, Revenue: $3.5BQ4'23, Net income: $737MQ4'23Q1'24, Revenue: $3.6BQ1'24, Net income: $801MQ1'24Q2'24, Revenue: $3.0BQ2'24, Net income: $713MQ2'24Q3'24, Revenue: $2.8BQ3'24, Net income: $638MQ3'24Q4'24, Revenue: $3.8BQ4'24, Net income: $665MQ4'24Q1'25, Net income: $906MQ1'25Q2'25, Net income: $461MQ2'25Q3'25, Net income: $77MQ3'25Q4'25, Net income: $352MQ4'25Q1'26, Net income: $1.0BQ1'26$0$2B$4B$6B$8BQ2'22, Revenue: $3.5BQ2'22, Net income: $559MQ3'22, Revenue: $3.6BQ3'22, Net income: $485MQ3'22Q4'22, Revenue: $3.5BQ4'22, Net income: $438MQ1'23, Revenue: $6.6BQ1'23, Net income: $969MQ1'23Q2'23, Revenue: $3.3BQ2'23, Net income: $603MQ3'23, Revenue: $3.3BQ3'23, Net income: $721MQ3'23Q4'23, Revenue: $3.5BQ4'23, Net income: $737MQ1'24, Revenue: $3.6BQ1'24, Net income: $801MQ1'24Q2'24, Revenue: $3.0BQ2'24, Net income: $713MQ3'24, Revenue: $2.8BQ3'24, Net income: $638MQ3'24Q4'24, Revenue: $3.8BQ4'24, Net income: $665MQ1'25, Net income: $906MQ1'25Q2'25, Net income: $461MQ3'25, Net income: $77MQ3'25Q4'25, Net income: $352MQ1'26, Net income: $1.0BQ1'26

Net income losses drawn in red.

Free cash flow
−$3B−$2B−$1B$0$1BQ2'22, Free cash flow: −$400MQ2'22Q3'22, Free cash flow: −$2.1BQ3'22Q4'22, Free cash flow: −$2.1BQ4'22Q1'23, Free cash flow: $150MQ1'23Q2'23, Free cash flow: −$695MQ2'23Q3'23, Free cash flow: −$400MQ3'23Q4'23, Free cash flow: −$1.2BQ4'23Q1'24, Free cash flow: −$82MQ1'24Q2'24, Free cash flow: −$1.2BQ2'24Q3'24, Free cash flow: −$913MQ3'24Q4'24, Free cash flow: −$1.1BQ4'24Q1'25, Free cash flow: −$854MQ1'25Q2'25, Free cash flow: −$1.5BQ2'25Q3'25, Free cash flow: −$1.5BQ3'25Q4'25, Free cash flow: −$2.2BQ4'25Q1'26, Free cash flow: −$652MQ1'26−$3B−$2B−$1B$0$1BQ2'22, Free cash flow: −$400MQ3'22, Free cash flow: −$2.1BQ3'22Q4'22, Free cash flow: −$2.1BQ1'23, Free cash flow: $150MQ1'23Q2'23, Free cash flow: −$695MQ3'23, Free cash flow: −$400MQ3'23Q4'23, Free cash flow: −$1.2BQ1'24, Free cash flow: −$82MQ1'24Q2'24, Free cash flow: −$1.2BQ3'24, Free cash flow: −$913MQ3'24Q4'24, Free cash flow: −$1.1BQ1'25, Free cash flow: −$854MQ1'25Q2'25, Free cash flow: −$1.5BQ3'25, Free cash flow: −$1.5BQ3'25Q4'25, Free cash flow: −$2.2BQ1'26, Free cash flow: −$652MQ1'26

Operating cash flow less capital expenditures; negative quarters in red.

Cash and equivalents against long-term debtCash and equivalentsLong-term debt
$0$500M$1.0B$1.5B$2.0BQ2'22, Cash and equivalents: $1.9BQ2'22Q3'22, Cash and equivalents: $685MQ3'22Q4'22, Cash and equivalents: $370MQ4'22Q1'23, Cash and equivalents: $534MQ1'23Q2'23, Cash and equivalents: $1.1BQ2'23Q3'23, Cash and equivalents: $1.1BQ3'23Q4'23, Cash and equivalents: $236MQ4'23Q1'24, Cash and equivalents: $606MQ1'24Q2'24, Cash and equivalents: $228MQ2'24Q3'24, Cash and equivalents: $560MQ3'24Q4'24, Cash and equivalents: $1.6BQ4'24Q1'25, Cash and equivalents: $1.7BQ1'25Q2'25, Cash and equivalents: $155MQ2'25Q3'25, Cash and equivalents: $5MQ3'25Q4'25, Cash and equivalents: $29MQ4'25Q1'26, Cash and equivalents: $794MQ1'26$0$500M$1.0B$1.5B$2.0BQ2'22, Cash and equivalents: $1.9BQ3'22, Cash and equivalents: $685MQ3'22Q4'22, Cash and equivalents: $370MQ1'23, Cash and equivalents: $534MQ1'23Q2'23, Cash and equivalents: $1.1BQ3'23, Cash and equivalents: $1.1BQ3'23Q4'23, Cash and equivalents: $236MQ1'24, Cash and equivalents: $606MQ1'24Q2'24, Cash and equivalents: $228MQ3'24, Cash and equivalents: $560MQ3'24Q4'24, Cash and equivalents: $1.6BQ1'25, Cash and equivalents: $1.7BQ1'25Q2'25, Cash and equivalents: $155MQ3'25, Cash and equivalents: $5MQ3'25Q4'25, Cash and equivalents: $29MQ1'26, Cash and equivalents: $794MQ1'26

Positions at each quarter end, as filed; short-term investments are not included.

Income statement

Last eight quarters, newest first, through Q1 FY2026 filed May 7, 2026.

Sempra income statement, quarterly
Millions of dollarsQ1 FY2026ended Mar 31, 2026filed May 7, 2026Q4 FY2025ended Dec 31, 2025filed Feb 26, 2026Q3 FY2025ended Sep 30, 2025filed Nov 5, 2025Q2 FY2025ended Jun 30, 2025filed Aug 7, 2025Q1 FY2025ended Mar 31, 2025filed May 8, 2025Q4 FY2024ended Dec 31, 2024filed Feb 25, 2025Q3 FY2024ended Sep 30, 2024filed Nov 6, 2024Q2 FY2024ended Jun 30, 2024filed Aug 6, 2024YoYQ1 FY2026vs Q1 FY2025
Revenue—————3,7582,7763,011—
Cost of revenue—————————
Gross profit—————————
Research and development—————————
Selling, general and administrative—————————
Operating income—————————
Other income (expense)100(30)495991(58)6530+9.9%
Pretax income9962372934677921,074332468+25.8%
Income tax65(10)48217257282(105)(130)+14.0%
Net income1,03735277461906665638713+14.5%
Diluted EPS ($)1.58—0.120.711.39—1.001.12+13.7%
Diluted shares (millions)655—654653653—638636—

Fourth quarters are the fiscal year less the first nine months when the filer reports no discrete fourth quarter, and are marked. Diluted EPS is never derived, so a derived quarter shows none. Italic figures are derived.

Balance sheet

Last eight quarters, newest first, through Q1 FY2026 filed May 7, 2026.

Sempra balance sheet, quarterly
Millions of dollarsQ1 FY2026ended Mar 31, 2026filed May 7, 2026Q4 FY2025ended Dec 31, 2025filed Feb 26, 2026Q3 FY2025ended Sep 30, 2025filed Nov 5, 2025Q2 FY2025ended Jun 30, 2025filed Aug 7, 2025Q1 FY2025ended Mar 31, 2025filed May 8, 2025Q4 FY2024ended Dec 31, 2024filed Feb 25, 2025Q3 FY2024ended Sep 30, 2024filed Nov 6, 2024Q2 FY2024ended Jun 30, 2024filed Aug 6, 2024YoYQ1 FY2026vs Q1 FY2025
Cash and equivalents7942951551,7391,565560228−54.3%
Short-term investments—————————
Total current assets36,20334,83731,7264,1695,6655,2855,0994,378+539.1%
Total assets113,518110,878106,91999,90799,01096,15593,74890,473+14.7%
Total current liabilities21,43921,89419,9888,6079,9349,6769,8439,540+115.8%
Long-term debt—————————
Total liabilities—————————
Stockholders’ equity32,23931,59431,15231,69731,64331,22229,70329,479+1.9%
Shares outstanding (millions)654653653652652651633633—

Positions at each period end. Nothing on this statement is derived. Long-term debt is the filed noncurrent line only; no total-debt composite is constructed across filers. Italic figures are derived.

Cash flow statement

Last eight quarters, newest first, through Q1 FY2026 filed May 7, 2026.

Sempra cash flow statement, quarterly
Millions of dollarsQ1 FY2026ended Mar 31, 2026filed May 7, 2026Q4 FY2025ended Dec 31, 2025filed Feb 26, 2026Q3 FY2025ended Sep 30, 2025filed Nov 5, 2025Q2 FY2025ended Jun 30, 2025filed Aug 7, 2025Q1 FY2025ended Mar 31, 2025filed May 8, 2025Q4 FY2024ended Dec 31, 2024filed Feb 25, 2025Q3 FY2024ended Sep 30, 2024filed Nov 6, 2024Q2 FY2024ended Jun 30, 2024filed Aug 6, 2024YoYQ1 FY2026vs Q1 FY2025
Operating cash flow1,8091,1891,1107841,4821,3651,022669+22.1%
Capital expenditures2,4613,4112,5612,3042,3362,4501,9351,897+5.4%
Free cash flow (CFO − capex)(652)(2,222)(1,451)(1,520)(854)(1,085)(913)(1,228)+23.7%
Depreciation and amortization621608662653640626614603−3.0%
Share repurchases2000157210−64.9%
Dividends paid409408408407380378380379+7.6%

10-Qs file cash flows as year-to-date totals, so quarterly figures are differenced from consecutive filings and marked. Free cash flow is operating cash flow less capital expenditures, computed from the two filed lines. Italic figures are derived.

Annual statements

Every fiscal year filed, newest first, through FY2025 filed February 26, 2026.

Income statement

Sempra income statement, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 26, 2026FY2024ended Dec 31, 2024filed Feb 25, 2025FY2023ended Dec 31, 2023filed Feb 27, 2024FY2022ended Dec 31, 2022filed Feb 28, 2023FY2021ended Dec 31, 2021filed Feb 25, 2022FY2020ended Dec 31, 2020filed Feb 25, 2021FY2019ended Dec 31, 2019filed Feb 27, 2020FY2018ended Dec 31, 2018filed Feb 26, 2019FY2017ended Dec 31, 2017filed Feb 27, 2018FY2016ended Dec 31, 2016filed Feb 28, 2017FY2015ended Dec 31, 2015filed Feb 26, 2016FY2014ended Dec 31, 2014filed Feb 26, 2015FY2013ended Dec 31, 2013filed Feb 27, 2014FY2012ended Dec 31, 2012filed Feb 26, 2013FY2011ended Dec 31, 2011filed Mar 14, 2012FY2010ended Dec 31, 2010filed Feb 24, 2011FY2009ended Dec 31, 2009filed Feb 26, 2010FY2008ended Dec 31, 2008filed Feb 24, 2011
Revenue13,70213,18516,72014,43912,85711,37010,82910,1029,64010,18310,23111,03510,5579,64710,0369,003——
Cost of revenue——————————————————
Gross profit——————————————————
Research and development——————————————————
Selling, general and administrative——————————————————
Operating income——————————————————
Other income (expense)1691361312458(48)7758220138126137140172130140149(109)
Pretax income1,7892,7133,2602,0098331,7831,7644781,2821,8301,7041,5241,4309431,7237871,4761,443
Income tax70121949055699249315(49)93838934130036659394133422438
Net income1,7962,8173,0302,0941,2543,7642,0559242561,3701,3491,1611,0018591,3317091,1191,113
Diluted EPS ($)2.754.424.793.312.016.44*3.65*1.71*0.51*2.73*2.69*2.31*2.00*1.74*2.75*1.43*2.26*2.21*
Diluted shares (millions)654638633633626585*564*540*505*502*502*501*499*493*483*496*495*502*

Balance sheet

Sempra balance sheet, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 26, 2026FY2024ended Dec 31, 2024filed Feb 25, 2025FY2023ended Dec 31, 2023filed Feb 27, 2024FY2022ended Dec 31, 2022filed Feb 28, 2023FY2021ended Dec 31, 2021filed Feb 25, 2022FY2020ended Dec 31, 2020filed Feb 25, 2021FY2019ended Dec 31, 2019filed Feb 27, 2020FY2018ended Dec 31, 2018filed Feb 26, 2019FY2017ended Dec 31, 2017filed Feb 27, 2018FY2016ended Dec 31, 2016filed Feb 28, 2017FY2015ended Dec 31, 2015filed Feb 26, 2016FY2014ended Dec 31, 2014filed Feb 26, 2015FY2013ended Dec 31, 2013filed Feb 27, 2014FY2012ended Dec 31, 2012filed Feb 26, 2013FY2011ended Dec 31, 2011filed Mar 14, 2012FY2010ended Dec 31, 2010filed Feb 24, 2011FY2009ended Dec 31, 2009filed Feb 26, 2010FY2008ended Dec 31, 2008filed Feb 24, 2011
Cash and equivalents291,565236370559960108102288349403570904475252912110331
Short-term investments——————————————————
Total current assets34,8375,2855,4705,9124,3754,5113,3393,6453,3413,1102,8914,1843,9973,6952,3323,3532,295—
Total assets110,87896,15587,18178,57472,04566,62365,66560,63850,45447,78641,15039,65137,16536,49933,24930,23128,512—
Total current liabilities21,8949,67610,0909,89910,0356,8399,1507,5236,6355,9274,6125,0694,3694,2584,1523,7863,888—
Long-term debt——————————————————
Total liabilities——————————————————
Stockholders’ equity31,59431,22228,67527,11525,98123,37319,92917,13812,67012,95111,80911,32611,00810,2829,7759,0279,007—
Shares outstanding (millions)653651632629*631*605*585*548*511*501*498*495*490*487*482*481*494*—

Cash flow statement

Sempra cash flow statement, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 26, 2026FY2024ended Dec 31, 2024filed Feb 25, 2025FY2023ended Dec 31, 2023filed Feb 27, 2024FY2022ended Dec 31, 2022filed Feb 28, 2023FY2021ended Dec 31, 2021filed Feb 25, 2022FY2020ended Dec 31, 2020filed Feb 25, 2021FY2019ended Dec 31, 2019filed Feb 27, 2020FY2018ended Dec 31, 2018filed Feb 26, 2019FY2017ended Dec 31, 2017filed Feb 27, 2018FY2016ended Dec 31, 2016filed Feb 28, 2017FY2015ended Dec 31, 2015filed Feb 26, 2016FY2014ended Dec 31, 2014filed Feb 26, 2015FY2013ended Dec 31, 2013filed Feb 27, 2014FY2012ended Dec 31, 2012filed Feb 26, 2013FY2011ended Dec 31, 2011filed Mar 14, 2012FY2010ended Dec 31, 2010filed Feb 24, 2011FY2009ended Dec 31, 2009filed Feb 26, 2010FY2008ended Dec 31, 2008filed Feb 24, 2011
Operating cash flow4,5654,9076,2181,1423,8422,5913,0883,5163,6252,3112,8982,1611,7842,0181,8672,1541,8751,191
Capital expenditures10,6128,2158,3975,3575,0154,6763,7083,5443,7054,2143,1563,1232,5722,9562,8442,0621,9122,061
Free cash flow (CFO − capex)(6,047)(3,308)(2,179)(4,215)(1,173)(2,085)(620)(28)(80)(1,903)(258)(962)(788)(938)(977)92(37)(870)
Depreciation and amortization2,5632,4372,2272,0191,8551,6661,5691,4911,4361,3121,2501,1561,1131,090976866775687
Share repurchases584332478339566262115567438451618502221,018
Dividends paid1,6031,4991,4831,4301,3311,174993877755686628598606550440364341339

Insider activity

Form 4 filings by officers, directors and 10% owners, November 1, 2024 to November 1, 2026. Only open-market purchases and sales count as buys and sells; awards, exercises, tax withholding and gifts are listed in grey and never counted.

Bought, three months
$0
0 purchases by 0 insiders; officers and directors $0
Sold, three months
$0
0 sales by 0 insiders; officers and directors $0
Bought, twelve months
$577K
3 purchases by 3 insiders; officers and directors $577K
Sold, twelve months
$8M
19 sales by 8 insiders; officers and directors $8M

The last 25 transactions

TradedInsiderRoleTransactionSharesPriceValueHeld afterFiled
Jun 17, 2026Winn Caroline AnnExecutive Vice Presidentopen-market sale100$89.85$9K33,064Jun 17, 2026
Jun 17, 2026Winn Caroline AnnExecutive Vice Presidentopen-market sale7,900$90.56$715K25,164Jun 17, 2026
May 18, 2026Ferrero PabloDirectoropen-market sale2,600$89.53$233K15,423May 19, 2026
May 14, 2026Day Diana LChief Legal Counselopen-market sale10b5-13,300$92.13$304K22,870May 14, 2026
May 12, 2026Weaving AnyaDirectoraward1,499$0.00—3,558May 13, 2026
May 12, 2026Mark Richard JDirectoraward1,499$0.00—18,913May 13, 2026
May 12, 2026Ferrero PabloDirectoraward1,499$0.00—18,599May 13, 2026
May 12, 2026Ferrero PabloDirectortax withholding576$93.41$54K18,023May 13, 2026
May 12, 2026Conesa AndresDirectoraward1,499$0.00—24,593May 13, 2026
May 12, 2026Conesa AndresDirectortax withholding576$93.41$54K24,018May 13, 2026
Apr 1, 2026Bird Justin ChristopherExecutive Vice Presidentopen-market sale10b5-11,128$96.69$109K21,632Apr 1, 2026
Mar 16, 2026Wold Dyan Z.VP, Controller and CAOopen-market sale10b5-11,539$95.38$147K4,633Mar 16, 2026
Mar 12, 2026Kirk Jennifer MDirectoropen-market buy1,000$93.44$93K1,000Mar 13, 2026
Mar 11, 2026Mark Richard JDirectoropen-market buy2,692$93.30$251K17,376Mar 11, 2026
Mar 11, 2026Warner Cynthia JDirectoropen-market buy2,500$92.95$232K11,275Mar 11, 2026
Mar 9, 2026Sedgwick Karen LExecutive VP and CFOopen-market sale10b5-11,186$93.52$111K39,029Mar 9, 2026
Mar 9, 2026Sedgwick Karen LExecutive VP and CFOopen-market sale10b5-12,699$92.61$250K40,215Mar 9, 2026
Mar 9, 2026Sedgwick Karen LExecutive VP and CFOopen-market sale10b5-1987$91.36$90K42,914Mar 9, 2026
Jan 27, 2026Sagara Kevin C.Directortax withholding3,605$87.11$314K4,890Jan 28, 2026
Jan 27, 2026Sagara Kevin C.Directoraward3,133$0.00—4,175Jan 28, 2026
Jan 27, 2026Sagara Kevin C.Directoraward4,320$0.00—8,495Jan 28, 2026
Jan 27, 2026Wold Dyan Z.VP, Controller and CAOaward310$0.00—5,999Jan 28, 2026
Jan 27, 2026Wold Dyan Z.VP, Controller and CAOaward427$0.00—6,426Jan 28, 2026
Jan 27, 2026Wold Dyan Z.VP, Controller and CAOtax withholding254$87.11$22K6,172Jan 28, 2026
Jan 27, 2026Winn Caroline AnnExecutive Vice Presidenttax withholding1,575$87.11$137K34,303Jan 28, 2026

Full insider history for Sempra, or insider activity across all companies. A record of filings, not a recommendation.

Sources

Fiscal year ends in month 12; periods are labeled with the issuer's own fiscal calendar. Values are as most recently filed (restatements apply; per-share values are on current split basis per the connector's split table, flagged in adjusted). Flow items flagged in `derived` were computed (Q4 = FY − nine months; quarterly cash flow differenced from year-to-date filings) rather than read from a filing. `reconciliation.repaired` lists periods where a full-year figure was filed in a quarter slot: that row was dropped and the quarter rebuilt from the annual figure. `reconciliation.quarantined` lists periods where four filed quarters do not sum to the filed year — those quarterly values are withheld, so a blank there is a withholding rather than an absence of reporting.

Filer
SEMPRA, CIK 1032208 on EDGAR
Extract generated
October 6, 2026
Withheld
none
Repaired
none
XBRL concepts behind each line

Income statement

Revenue: Revenues
Cost of revenue: not filed
Gross profit: not filed
Research and development: not filed
Selling, general and administrative: not filed
Operating income: not filed
Other income (expense): NonoperatingIncomeExpense, OtherNonoperatingIncomeExpense
Pretax income: IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest, IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
Income tax: IncomeTaxExpenseBenefit
Net income: NetIncomeLoss, NetIncomeLossAvailableToCommonStockholdersBasic
Diluted EPS ($): EarningsPerShareDiluted
Diluted shares (millions): WeightedAverageNumberOfDilutedSharesOutstanding

Balance sheet

Cash and equivalents: CashAndCashEquivalentsAtCarryingValue
Short-term investments: not filed
Total current assets: AssetsCurrent
Total assets: Assets
Total current liabilities: LiabilitiesCurrent
Long-term debt: not filed
Total liabilities: not filed
Stockholders’ equity: StockholdersEquity
Shares outstanding (millions): dei:EntityCommonStockSharesOutstanding

Cash flow statement

Operating cash flow: NetCashProvidedByUsedInOperatingActivities
Capital expenditures: PaymentsToAcquireProductiveAssets, PaymentsToAcquirePropertyPlantAndEquipment
Free cash flow (CFO − capex): not filed
Depreciation and amortization: DepreciationAndAmortization, DepreciationDepletionAndAmortization
Share repurchases: PaymentsForRepurchaseOfCommonStock
Dividends paid: PaymentsOfDividendsCommonStock

The data

The statements on this page as files, generated October 6, 2026.

JSON file
/data/financials/SRE.json